Over a 3-year period from 2016 to 2018, RMEI produced 10 live and 5 enduring online medical education courses that addressed optimal strategies for managing AMR and CMV in SOT patients, and CMV in HSCT patients. The education targeted both domestic and international audiences. Key: antibody-mediated rejection (AMR); cytomegalovirus (CMV); hematopoietic stem cell transplantation (HSCT); solid organ transplantation (SOT).